179 related articles for article (PubMed ID: 18286527)
1. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
Scotté F; Banu E; Medioni J; Levy E; Ebenezer C; Marsan S; Banu A; Tourani JM; Andrieu JM; Oudard S
Cancer; 2008 Apr; 112(7):1625-31. PubMed ID: 18286527
[TBL] [Abstract][Full Text] [Related]
2. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.
Scotté F; Tourani JM; Banu E; Peyromaure M; Levy E; Marsan S; Magherini E; Fabre-Guillevin E; Andrieu JM; Oudard S
J Clin Oncol; 2005 Jul; 23(19):4424-9. PubMed ID: 15994152
[TBL] [Abstract][Full Text] [Related]
3. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
Can G; Aydiner A; Cavdar I
Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
[TBL] [Abstract][Full Text] [Related]
4. Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial.
McCarthy AL; Shaban RZ; Gillespie K; Vick J
Support Care Cancer; 2014 May; 22(5):1375-83. PubMed ID: 24362908
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic management for taxane-induced nail toxicity: A systematic review and meta-analysis.
Huang KL; Lin KY; Huang TW; Loh EW; Hua YM; Su HC; Tam KW
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13118. PubMed ID: 31184794
[TBL] [Abstract][Full Text] [Related]
6. Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial.
Mazzega-Fabbro C; Polesel J; Spazzapan S; Meneghetti L; Montagner D; Tabaro G; Bartoletti M; Puglisi F
Clin Breast Cancer; 2023 Jun; 23(4):447-453. PubMed ID: 36997403
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy.
Kim JY; Ok ON; Seo JJ; Lee SH; Ahn JS; Im YH; Park YH
Breast Cancer Res Treat; 2017 Aug; 164(3):617-625. PubMed ID: 28488142
[TBL] [Abstract][Full Text] [Related]
8. Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients.
Ishiguro H; Takashima S; Yoshimura K; Yano I; Yamamoto T; Niimi M; Yamashiro H; Ueno T; Takeuchi M; Sugie T; Yanagihara K; Toi M; Fukushima M
Support Care Cancer; 2012 Sep; 20(9):2017-24. PubMed ID: 22086405
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-induced nail toxicity: a case of severe onycholysis and topic review.
Lau CP; Hui P; Chan TC
Chin Med J (Engl); 2011 Aug; 124(16):2559-60. PubMed ID: 21933605
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel-induced acral erythema and nail changes distributed to photoexposed areas.
Ferreira O; Baudrier T; Mota A; Duarte AF; Azevedo F
Cutan Ocul Toxicol; 2010 Dec; 29(4):296-9. PubMed ID: 20608863
[TBL] [Abstract][Full Text] [Related]
11. Frostbite as a complication of frozen gloves in the prevention of docetaxel-induced onycholysis.
Begon E; Blum L; Fraboulet G; Assouad S; Bachmeyer C
Eur J Dermatol; 2011; 21(4):628-9. PubMed ID: 21697040
[No Abstract] [Full Text] [Related]
12. Nail toxicity induced by cancer chemotherapy.
Gilbar P; Hain A; Peereboom VM
J Oncol Pharm Pract; 2009 Sep; 15(3):143-55. PubMed ID: 19171552
[TBL] [Abstract][Full Text] [Related]
13. [Onycholysis due to docetaxel in breast cancer treatment].
Grasland A; Grandjean M; Rist S; Bosquet A; Vinceneux P
Rev Med Interne; 2005 May; 26(5):427-8. PubMed ID: 15893036
[No Abstract] [Full Text] [Related]
14. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
15. Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: a pilot study.
Freyer G; Hennebert P; Awada A; Gil T; Kerger J; Selleslags J; Brassinne C; Piccart M; de Valeriola D
Clin Cancer Res; 2002 Jan; 8(1):95-102. PubMed ID: 11801544
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly.
ten Tije AJ; Verweij J; Carducci MA; Graveland W; Rogers T; Pronk T; Verbruggen MP; Dawkins F; Baker SD
J Clin Oncol; 2005 Feb; 23(6):1070-7. PubMed ID: 15718305
[TBL] [Abstract][Full Text] [Related]
17. Severe nail changes due to Docetaxel treatment.
Rafi L; Friedrich M; Tilgen W; Reichrath J
Eur J Dermatol; 2003; 13(6):610-1. PubMed ID: 14721789
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of dose-dense docetaxel followed by doxorubicin with cyclophosphamide as adjuvant therapy for breast cancer in a phase II study.
Lambert-Falls R; Modugno S
Clin Breast Cancer; 2007 Aug; 7(9):697-704. PubMed ID: 17919350
[TBL] [Abstract][Full Text] [Related]
19. Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
Schuette W; Nagel S; Blankenburg T; Lautenschlaeger C; Hans K; Schmidt EW; Dittrich I; Schweisfurth H; von Weikersthal LF; Raghavachar A; Reissig A; Serke M
J Clin Oncol; 2005 Nov; 23(33):8389-95. PubMed ID: 16293869
[TBL] [Abstract][Full Text] [Related]
20. Onycholysis associated with weekly administration of paclitaxel.
Flory SM; Solimando DA; Webster GF; Dunton CJ; Neufeld JM; Haffey MB
Ann Pharmacother; 1999 May; 33(5):584-6. PubMed ID: 10369623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
